Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 7 matching records.
7 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
The role of non-coding RNA regulates stem cell programmed death in disease therapy
Narrative Review, published in Noncoding RNA Res (2025) — summary generated from the PubMed abstract.
- 2025
Noncoding RNA Res7 citations - Level DNarrative ReviewEurope PMC
Targeting Programmed Cell Death in Flap Ischemia/Reperfusion Injury
Narrative Review on Systemic / IV, published in Biomolecules (2025) — summary generated from the PubMed abstract.
- 2025
Biomolecules3 citations - Level DNarrative ReviewEurope PMC
The role of programmed cell death in diabetic foot ulcers
Narrative Review on Diabetic Foot, published in Int Wound J (2024) — summary generated from the PubMed abstract.
- 2024
Int Wound J9 citations - Level DNarrative ReviewEurope PMC
Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications
Narrative Review on Chronic Inflammation, published in World J Stem Cells (2021) — summary generated from the PubMed abstract.
- 2021
World J Stem Cells26 citations - Level DNarrative ReviewEurope PMC
Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases
Narrative Review on Systemic / IV, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol24 citations - Level DAnimal StudyPubMed
Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Animal Study on Immune Modulation, Autoimmune Research, published in J Tissue Eng Regen Med (2017) — summary generated from the PubMed abstract.
- 2017
J Tissue Eng Regen Med - Level DLaboratory StudyEurope PMC
miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1
Laboratory Study on Cardiovascular Disease, published in PLoS One (2013) — summary generated from the PubMed abstract.
- 2013
PLoS One79 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406